Back

Introduction - Management of CV disease in type 2 diabetes.

29 August 2017 (15:45 - 15:50)
Organised by:
Congress Presentation Part of: Cardiovascular risk in type 2 diabetes & recent outcome trials: how will they influence clinical decision making? Diabetes, dysglycaemia and metabolic syndrome ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor John Eric Deanfield

University College London, London (United Kingdom of Great Britain & Northern Ireland)

2 More presentations in this session

Presentation thumbnail
Brief update on the LEADER cardiovascular outcomes trial.
Professor N. Poulter (London, GB)
Presentation thumbnail
Interactive discussion - Results from CVOTs in type 2 diabetes: how will they inform clinical decision making?
Professor J. Deanfield (London, GB) Professor N. Poulter (London, GB)

Access the full session

Session thumbnail
Cardiovascular risk in type 2 diabetes & recent outcome trials: how will they influence clinical decision making?

The Event

Event poster

ESC Congress 2017

29 August 2017 15:45 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources